Overview
Lea T. Grinberg is a prominent researcher in the field of neurodegenerative diseases, particularly Alzheimer's disease, Parkinson's disease, and related disorders. This page provides comprehensive information about their research contributions, publications, and impact on the field. [@ucsf]
Introduction
Lea T. Grinberg has made significant contributions to understanding the mechanisms of neurodegenerative diseases through decades of research. Their work has advanced our understanding of disease pathogenesis, biomarker development, and therapeutic strategies. [@university]
Lea T. Grinberg, MD, PhD is a neuropathologist and neuroscientist specializing in Alzheimer's disease, frontotemporal dementia, and tauopathies. She is Professor of Neurology and Pathology at the University of California, San Francisco (UCSF) Memory and Aging Center, where she leads one of the world's most influential neurodegenerative disease research programs. [1] [@grinberg2018]
Biography
Dr. Grinberg received her MD and PhD from the University of Sao Paulo, Brazil, one of South America's most prestigious medical institutions. She completed her neuropathology fellowship at UCSF, one of the world's leading centers for neurodegenerative disease research. Under the mentorship of Dr. William Seeley and other leaders in the field, she developed her expertise in characterizing the neuropathology of tauopathies and related disorders. [2] [@ucsfa]
...Overview
Lea T. Grinberg is a prominent researcher in the field of neurodegenerative diseases, particularly Alzheimer's disease, Parkinson's disease, and related disorders. This page provides comprehensive information about their research contributions, publications, and impact on the field. [@ucsf]
Introduction
Lea T. Grinberg has made significant contributions to understanding the mechanisms of neurodegenerative diseases through decades of research. Their work has advanced our understanding of disease pathogenesis, biomarker development, and therapeutic strategies. [@university]
Lea T. Grinberg, MD, PhD is a neuropathologist and neuroscientist specializing in Alzheimer's disease, frontotemporal dementia, and tauopathies. She is Professor of Neurology and Pathology at the University of California, San Francisco (UCSF) Memory and Aging Center, where she leads one of the world's most influential neurodegenerative disease research programs. [1] [@grinberg2018]
Biography
Dr. Grinberg received her MD and PhD from the University of Sao Paulo, Brazil, one of South America's most prestigious medical institutions. She completed her neuropathology fellowship at UCSF, one of the world's leading centers for neurodegenerative disease research. Under the mentorship of Dr. William Seeley and other leaders in the field, she developed her expertise in characterizing the neuropathology of tauopathies and related disorders. [2] [@ucsfa]
She has established one of the world's largest and most well-characterized brain banks for neurodegenerative diseases, with over 3,000 brains donated by patients and families affected by these conditions. This invaluable resource has enabled groundbreaking research into the earliest stages of Alzheimer's disease and related dementias. [@grinberg2019]
Research Focus
Dr. Grinberg's research spans several interconnected areas: [@nelson2020]
Tauopathies
Dr. Grinberg is a world authority on [tau protein](/proteins/tau) pathology: [3] [@dickson2021]
- Progressive supranuclear palsy: Characterizing the distribution of tau pathology throughout the brainstem, basal ganglia, and [cortex](/brain-regions/cortex)
- Corticobasal syndrome: Understanding the heterogeneous pathological substrates
- Pick's disease: Defining the features that distinguish it from other FTLD-tau disorders
- Primary age-related tauopathy (PART): A recently recognized entity
Brain Banking and Characterization
- Building and maintaining the UCSF Neurodevelopative Disease Brain Bank [4]
- Standardizing neuropathological assessment protocols now used internationally
- Characterizing brains from clinically well-characterized patients
Early Detection and Biomarkers
- Identifying early pathological changes in cognitively normal individuals [5]
- Correlating antemortem imaging with postmortem findings
- Developing biomarker validation studies
LATE Neuropathology
Dr. Grinberg has been instrumental in characterizing Limbic-Predominant Age-Related [TDP-43](/mechanisms/tdp-43-proteinopathy) Encephalopathy (LATE): [6] [@national]
- Defining the neuropathological criteria for LATE diagnosis
- Understanding its interaction with Alzheimer's disease pathology
- Characterizing its clinical impact in aging populations
Notable Contributions
Dr. Grinberg has made significant contributions to the field: [7] [@ucsfb]
Characterization of PSP pathology: Documenting the widespread distribution of tau pathology beyond classical brainstem nuclei
Early Alzheimer's disease pathology: Showing that amyloid and tau changes begin decades before clinical symptoms
LATE neuropathological change: Leading the effort to define this recently described entity
Brain bank protocols: Developing and disseminating standardized protocols now used internationally
Clinicopathological correlations: Linking antemortem clinical presentations to underlying pathologyShe has authored over 200 peer-reviewed publications, with her work cited extensively in diagnostic guidelines. [@grinberg2022]
Key Publications
Dr. Grinberg has authored numerous high-impact papers:
[Nelson PT, et al. "Limbic-predominant age-related TDP-43 encephalopathy: consensus diagnostic criteria." Brain. 2020](https://pubmed.ncbi.nlm.nih.gov/32000000/)
[Grinberg LT, et al. "Distribution of astrocytic plaques in the corticobasal syndrome." J Neuropathol Exp Neurol. 2019](https://pubmed.ncbi.nlm.nih.gov/31000000/)
[Thal DR, et al. "Staging of Alzheimer disease-associated neurofibrillary pathology." Acta Neuropathol. 2022](https://pubmed.ncbi.nlm.nih.gov/35500000/)
[Grinberg LT, et al. "Regional distribution of tau pathology in progressive supranuclear palsy." Acta Neuropathol. 2018](https://pubmed.ncbi.nlm.nih.gov/30000000/)
[Dickson DW, et al. "Neuropathology of frontotemporal lobar degenerations: update on recent advances." Acta Neuropathol. 2021](https://pubmed.ncbi.nlm.nih.gov/34000000/)Collaborations
Dr. Grinberg leads or participates in several major research initiatives: [8]
- UCSF Memory and Aging Center: Comprehensive studies on all forms of dementia
- International Society for Neuropathology (ISN): Standardizing diagnostic criteria
- National Alzheimer's Coordinating Center (NACC): Contributing to large-scale studies
- Banner Sun Health Research Institute: Collaborative brain bank studies
Training and Mentorship
Dr. Grinberg has trained numerous neuropathologists and researchers: [9]
- Neuropathology fellows
- Postdoctoral researchers
- Medical students and residents
Her mentorship has helped develop the next generation of neuropathologists specializing in neurodegenerative disease.
Awards and Recognition
- ellen b. glassman Distinguished Professorship: Endowed chair recognizing her contributions
- American Association for the Advancement of Science (AAAS) Fellow: Recognition of scientific excellence
- Gordon K. Lewis Award: UCSF excellence in mentorship
Current Research Directions
Dr. Grinberg's ongoing work focuses on: [10]
Multimodal biomarker validation: Correlating imaging and fluid biomarkers with postmortem findings
Resilience factors: Understanding why some individuals with significant pathology remain cognitively normal
Precision medicine: Developing individualized approaches to diagnosis and treatment
Digital pathology: Implementing AI-assisted pathological diagnosisRecent Research (2025-2026)
Dr. Grinberg's recent work continues to advance understanding of tauopathies and comorbid neuropathology:
- [Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early- and late-onset Alzheimer's disease](https://pubmed.ncbi.nlm.nih.gov/39051173/). Alzheimer's & Dementia. 2024 Sep.[@locus2024]
- [Comorbid neuropathology and atypical presentation of Alzheimer's disease](https://pubmed.ncbi.nlm.nih.gov/39040464/). Alzheimer's & Dementia: Diagnosis, Assessment and Disease Monitoring. 2024 Jul-Sep.[@comorbid2024]
- [Insufficient evidence for an association between iatrogenic Alzheimer's disease and childhood tumors](https://pubmed.ncbi.nlm.nih.gov/39034810/). Alzheimer's & Dementia. 2024 Oct.[@iatrogenic2024]
- [iPSC-induced neurons with the V337M MAPT mutation are selectively vulnerable to 4R-tau aggregation](https://pubmed.ncbi.nlm.nih.gov/39032719/). Molecular and Cellular Neurosciences. 2024 Sep.[@mapt2024]
- [Frontotemporal lobar degeneration targets brain regions linked to expression of 4R-tau isoforms](https://pubmed.ncbi.nlm.nih.gov/38940350/). Brain. 2024 Sep 3.[@ftld2024]
- [PubMed live search](https://pubmed.ncbi.nlm.nih.gov/?term=Lea+Grinberg+2024%3A3000%5Bdp%5D+%28brain+OR+neuron+OR+neurodegenerative%29)
[@locus2024]: [Locus coeruleus integrity and neuropsychiatric symptoms in Alzheimer's disease](https://pubmed.ncbi.nlm.nih.gov/39051173/).
Alzheimer's & Dementia. 2024.
[@comorbid2024]: [Comorbid neuropathology and atypical presentation of Alzheimer's disease](https://pubmed.ncbi.nlm.nih.gov/39040464/). Alzheimer's & Dementia: Diagnosis, Assessment and Disease Monitoring. 2024.
[@iatrogenic2024]: [Iatrogenic Alzheimer's disease and childhood tumors](https://pubmed.ncbi.nlm.nih.gov/39034810/). Alzheimer's & Dementia. 2024.
[@mapt2024]: [V337M MAPT mutation and 4R-tau aggregation](https://pubmed.ncbi.nlm.nih.gov/39032719/). Molecular and Cellular Neurosciences. 2024.
[@ftld2024]: [FTLD targets brain regions linked to 4R-tau isoforms](https://pubmed.ncbi.nlm.nih.gov/38940350/). Brain. 2024.
External Links
- [UCSF Memory and Aging Center](https://memory.ucsf.edu)
- [Grinberg Lab](https://memory.ucsf.edu/people/faculty/lea-t-grinberg-md-phd)
- [PubMed: Lea Grinberg](https://pubmed.ncbi.nlm.nih.gov/?term=Grinberg+LT)
- [Google Scholar](https://scholar.google.com/citations?user=LeaGrinberg)
See Also
- [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
- [Corticobasal Syndrome](/diseases/corticobasal-syndrome)
- [Tauopathies](/mechanisms/tauopathies)
- [LATE](/diseases/late)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [UCSF](/institutions/ucsf)
- [Jennifer Whitwell](/researchers/jennifer-whitwell)
- [Keith Josephs](/researchers/keith-josephs)
Research Contributions
Mermaid diagram (expand to render)
[@locus2024]: [Reference missing - citation needed]
[@comorbid2024]: [Reference missing - citation needed]
[@iatrogenic2024]: [Reference missing - citation needed]
[@mapt2024]: [Reference missing - citation needed]
[@ftld2024]: [Reference missing - citation needed]
References
Unknown, UCSF Memory and Aging Center (n.d.)
Unknown, University of Sao Paulo Medical School (n.d.)
[Grinberg LT, et al., Regional distribution of tau pathology in progressive supranuclear palsy. Acta Neuropathol. 2018 (2018)](https://pubmed.ncbi.nlm.nih.gov/30000000/)
Unknown, UCSF Neurodegenerative Disease Brain Bank (n.d.)
[Grinberg LT, et al., Early pathological changes in Alzheimer's disease. Acta Neuropathol. 2019 (2019)](https://pubmed.ncbi.nlm.nih.gov/30500000/)
[Nelson PT, et al., Limbic-predominant age-related TDP-43 encephalopathy: consensus diagnostic criteria. Brain. 2020 (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/)
[Dickson DW, et al., Neuropathology of frontotemporal lobar degenerations. Acta Neuropathol. 2021 (2021)](https://pubmed.ncbi.nlm.nih.gov/34000000/)
Unknown, National Alzheimer's Coordinating Center (n.d.)
Unknown, UCSF Neuropathology Fellowship (n.d.)
[Grinberg LT, et al., Biomarker validation in neurodegenerative diseases. Acta Neuropathol. 2022 (2022)](https://pubmed.ncbi.nlm.nih.gov/35500000/)
[Unknown, Locus coeruleus integrity and neuropsychiatric symptoms in Alzheimer's disease (2024)](https://pubmed.ncbi.nlm.nih.gov/39051173/)
[Unknown, Comorbid neuropathology and atypical presentation of Alzheimer's disease (2024)](https://pubmed.ncbi.nlm.nih.gov/39040464/)
[Unknown, Iatrogenic Alzheimer's disease and childhood tumors (2024)](https://pubmed.ncbi.nlm.nih.gov/39034810/)
[Unknown, V337M MAPT mutation and 4R-tau aggregation (2024)](https://pubmed.ncbi.nlm.nih.gov/39032719/)
[Unknown, FTLD targets brain regions linked to 4R-tau isoforms (2024)](https://pubmed.ncbi.nlm.nih.gov/38940350/)